Azilsartan Kamedoxomil

14 API suppliersSmall Molecule

Overview

Azilsartan Kamedoxomil is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2103795).

API suppliers (14)

Suppliers of Azilsartan Kamedoxomil evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India7China6

Country recorded for 13 of 14 suppliers.

5 of 14 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (4 approved US products), the latest listed US patent on Azilsartan Kamedoxomil expires 26 Mar 2028 and exclusivity 12 Dec 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
potassium 3-[2-[4-[[2-ethoxy-7-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]benzimidazol-1-yl]methyl]phenyl]phenyl]-1,2,4-oxadiazol-5-olate
Canonical SMILES
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=N5)[O-])C(=O)OCC6=C(OC(=O)O6)C.[K+]
InChIKey
IHWFKDWIUSZLCJ-UHFFFAOYSA-M
Verified Supplier Partner

Do you supply Azilsartan Kamedoxomil? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.